Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, January 2000, p. 24-29, Vol. 44, No. 1
Centre de Recherche en Sciences et
Technologie du Lait (STELA), Faculté des Sciences de
l'Agriculture et de l'Alimentation,1 and
Département de Biochimie, Faculté de Sciences
et Génie,2 Université Laval,
Cité Universitaire, Québec, Québec, Canada G1K 7P4
Received 3 February 1999/Returned for modification 31 May
1999/Accepted 10 October 1999
Peptide antibiotics, particularly lantibiotics, are good candidates
for replacing antibiotics to which bacteria have become resistant. In
order to compare two such lantibiotics with two antibiotics, the MICs
of nisin A, mutacin B-Ny266, vancomycin, and oxacillin against various
bacterial pathogens were determined. The results indicate that nisin A
and mutacin B-Ny266 are as active as vancomycin and oxacillin against
most of the strains tested. Furthermore, mutacin B-Ny266 remains active
against strains that are resistant to nisin A, oxacillin, or
vancomycin. The wide spectrum of activity of mutacin B-Ny266, its low
MICs against bacterial pathogens, and its activity against bacteria
resistant to other inhibitors support the development of this substance
for therapeutic use.
0066-4804/0/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
MICs of Mutacin B-Ny266, Nisin A, Vancomycin,
and Oxacillin against Bacterial Pathogens
*
Corresponding author. Mailing address:
Département de Biochimie, Faculté de Sciences et
Génie, Université Laval, Cité Universitaire,
Québec, Québec, Canada G1K 7P4. Phone: (418) 656-2131, ext.
2151. Fax: (418) 656-3664. E-mail:
Marc.Lavoie{at}bcm.ulaval.ca.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»